Performance enhancers
This article was originally published in The Tan Sheet
Executive Summary
"It would be inappropriate and illegal for any manufacturer of any nutritional supplement to include any unlabeled ingredient, including nandrolone," CRN says Sept. 27, responding to allegations made at the Summer Olympics about mislabeled supplements. U.S. shot putter C.J. Hunter, who did not compete in Sydney, stated his positive drug tests earlier this summer may have resulted from use of nutritional supplements. Nandrolone is an anabolic steroid banned by the International Olympic Committee. Performance-enhancing drugs are the primary focus of the newly established White House Task Force on Drug Use in Sports, formed in August and expected to release a preliminary report early next year (1"The Tan Sheet" Aug. 21, p. 3)
You may also be interested in...
Nandrolone in the U.K.
Medicines Control Agency notifying 20 manufacturers of supplements containing nandrolone precursors that such products must be licensed under the Medicines Act. Manufacturers will be obligated to stop selling products in nonprescription settings immediately upon receipt of MCA's letter. The action, which affects about 50 products, is taken following MCA's investigation of a complaint about such supplements. Issues involving nandrolone and nandrolone precursors in supplements also arose during the 2000 Sydney Olympics (1"The Tan Sheet" Oct. 2, 2000, In Brief)
White House Sports Drug Task Force Preliminary Report Expected Early 2001
Sports nutritional supplements such as androstenedione and ephedrine, which are banned in international Olympic competition but legally available in the U.S., could be subjected to new scrutiny by a national task force on performance-enhancing substances.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC